Larry Léon

1.7k total citations
23 papers, 1.3k citations indexed

About

Larry Léon is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Larry Léon has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Statistics and Probability, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Larry Léon's work include Statistical Methods and Inference (6 papers), Statistical Methods in Clinical Trials (5 papers) and Statistical Methods and Bayesian Inference (4 papers). Larry Léon is often cited by papers focused on Statistical Methods and Inference (6 papers), Statistical Methods in Clinical Trials (5 papers) and Statistical Methods and Bayesian Inference (4 papers). Larry Léon collaborates with scholars based in United States, Cyprus and Germany. Larry Léon's co-authors include Ennapadam Venkatraman, Murray F. Brennan, Martin S. Karpeh, David S. Klimstra, Robert J. Ginsberg, Valerie W. Rusch, Robert J. Downey, Adam Raben, Kenneth E. Rosenzweig and Louis B. Harrison and has published in prestigious journals such as Cancer, Annals of Surgery and Biometrics.

In The Last Decade

Larry Léon

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry Léon United States 12 770 428 264 211 163 23 1.3k
Mauro Orlando United States 22 926 1.2× 515 1.2× 483 1.8× 1.1k 5.0× 72 0.4× 88 1.9k
Giovanni M. Bariani Brazil 12 201 0.3× 219 0.5× 119 0.5× 443 2.1× 32 0.2× 32 839
Masashi Wakabayashi Japan 23 1.9k 2.5× 808 1.9× 203 0.8× 1.4k 6.5× 515 3.2× 136 3.2k
R. Sylvester Belgium 21 976 1.3× 686 1.6× 59 0.2× 637 3.0× 61 0.4× 54 1.9k
Anja H. Loos Germany 10 605 0.8× 331 0.8× 120 0.5× 1.6k 7.4× 66 0.4× 16 2.0k
Stefano Tamberi Italy 20 303 0.4× 276 0.6× 114 0.4× 555 2.6× 50 0.3× 59 1.0k
Elisa Meldolesi Italy 18 359 0.5× 225 0.5× 42 0.2× 398 1.9× 432 2.7× 46 1.0k
G.J. Creemers Netherlands 12 631 0.8× 572 1.3× 89 0.3× 1.5k 7.1× 89 0.5× 23 2.0k
Stephen A. Cullinan United States 15 703 0.9× 389 0.9× 35 0.1× 1.4k 6.6× 28 0.2× 25 1.8k
J.T. Thigpen 18 190 0.2× 264 0.6× 297 1.1× 418 2.0× 73 0.4× 95 1.0k

Countries citing papers authored by Larry Léon

Since Specialization
Citations

This map shows the geographic impact of Larry Léon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Léon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Léon more than expected).

Fields of papers citing papers by Larry Léon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Léon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Léon. The network helps show where Larry Léon may publish in the future.

Co-authorship network of co-authors of Larry Léon

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Léon. A scholar is included among the top collaborators of Larry Léon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Léon. Larry Léon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yujie, et al.. (2025). Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects. Contemporary Clinical Trials. 152. 107860–107860.
2.
Léon, Larry, Thomas Jemielita, Zifang Guo, Rachel Marceau West, & Keaven M. Anderson. (2024). Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedure. Statistics in Medicine. 43(20). 3921–3942.
3.
Lin, Ray, Pralay Mukhopadhyay, Satrajit Roychoudhury, et al.. (2023). Comment on “Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group. Statistics in Biopharmaceutical Research. 15(2). 312–314. 1 indexed citations
4.
Lin, Ray, Ji Lin, Satrajit Roychoudhury, et al.. (2020). Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis. Figshare. 30 indexed citations
5.
Lin, Ray & Larry Léon. (2017). Estimation of treatment effects in weighted log-rank tests. Contemporary Clinical Trials Communications. 8. 147–155. 29 indexed citations
6.
7.
Léon, Larry, Tianxi Cai, & L. J. Wei. (2009). Robust Inferences for Covariate Effects on Survival Time with Censored Linear Regression Models. Statistics in Biosciences. 1(1). 50–64. 4 indexed citations
8.
Dutcher, Janice P., Larry Léon, Judith Manola, et al.. (2005). Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy. Cancer. 104(11). 2392–2399. 26 indexed citations
9.
Léon, Larry & Chih‐Ling Tsai. (2004). Functional Form Diagnostics for Cox's Proportional Hazards Model. Biometrics. 60(1). 75–84. 8 indexed citations
10.
Dennis, S., John B. Liao, Larry Léon, et al.. (2001). Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma. Gynecologic Oncology. 82(3). 532–537. 201 indexed citations
11.
Makhija, Sharmila, Mario M. Leitão, Paul Sabbatini, et al.. (2001). Complications Associated with Intraperitoneal Chemotherapy Catheters. Gynecologic Oncology. 81(1). 77–81. 79 indexed citations
12.
Rusch, Valerie W., Kenneth E. Rosenzweig, Ennapadam Venkatraman, et al.. (2001). A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. Journal of Thoracic and Cardiovascular Surgery. 122(4). 788–795. 353 indexed citations
13.
Hensley, Martee L., Bradford S. Hoppe, Larry Léon, et al.. (2001). The Costs and Efficacy of Liposomal Doxorubicin in Platinum-Refractory Ovarian Cancer in Heavily Pretreated Patients. Gynecologic Oncology. 82(3). 464–469. 21 indexed citations
14.
Hensley, Martee L., Larry Léon, Ennapadam Venkatraman, et al.. (2001). Identification of Risk Factors for Requiring Transfusion during Front-Line Chemotherapy for Ovarian Cancer. Gynecologic Oncology. 81(3). 485–489. 11 indexed citations
15.
Downey, Robert J., Valerie W. Rusch, Florence Ida Hsu, et al.. (2000). Chest wall resection for locally recurrent breast cancer: Is it worthwhile?. Journal of Thoracic and Cardiovascular Surgery. 119(3). 420–428. 47 indexed citations
16.
Rusch, Valerie W., Kalpaj R. Parekh, Larry Léon, et al.. (2000). Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. Journal of Thoracic and Cardiovascular Surgery. 119(6). 1147–1153. 105 indexed citations
17.
Karpeh, Martin S., Larry Léon, David S. Klimstra, & Murray F. Brennan. (2000). Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?. Annals of Surgery. 232(3). 362–371. 263 indexed citations
18.
Krug, Lee M., Kenneth Ng, Mark G. Kris, et al.. (2000). Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.. PubMed. 6(9). 3493–8. 48 indexed citations
19.
Léon, Larry & Chih‐Ling Tsai. (1998). Assessment of model adequacy for Markov regression time series models.. PubMed. 54(3). 1165–75. 7 indexed citations
20.
Léon, Larry & Chih‐Ling Tsai. (1998). Assessment of Model Adequacy for Markov Regression Time Series Models. Biometrics. 54(3). 1165–1165. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Orlando Breakdown of academic impact, for papers by Giovanni M. Bariani Breakdown of academic impact, for papers by Masashi Wakabayashi Breakdown of academic impact, for papers by R. Sylvester Breakdown of academic impact, for papers by Anja H. Loos Breakdown of academic impact, for papers by Stefano Tamberi Breakdown of academic impact, for papers by Elisa Meldolesi Breakdown of academic impact, for papers by G.J. Creemers Breakdown of academic impact, for papers by Stephen A. Cullinan Breakdown of academic impact, for papers by J.T. Thigpen
Rankless by CCL
2026